584 related articles for article (PubMed ID: 27363760)
1. Overview of Botulinum Toxins for Aesthetic Uses.
Gart MS; Gutowski KA
Clin Plast Surg; 2016 Jul; 43(3):459-71. PubMed ID: 27363760
[TBL] [Abstract][Full Text] [Related]
2. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I
Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin: examining duration of effect in facial aesthetic applications.
Flynn TC
Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin Use in the Upper Face.
Qaqish C
Atlas Oral Maxillofac Surg Clin North Am; 2016 Sep; 24(2):95-103. PubMed ID: 27499468
[No Abstract] [Full Text] [Related]
5. Botulinum toxin products overview.
Carruthers A; Carruthers J
Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
[TBL] [Abstract][Full Text] [Related]
6. Advances in the use of botulinum neurotoxins in facial esthetics.
Flynn TC
J Cosmet Dermatol; 2012 Mar; 11(1):42-50. PubMed ID: 22360334
[TBL] [Abstract][Full Text] [Related]
7. Aesthetic Uses of Neuromodulators: Current Uses and Future Directions.
Gart MS; Gutowski KA
Plast Reconstr Surg; 2015 Nov; 136(5 Suppl):62S-71S. PubMed ID: 26441114
[TBL] [Abstract][Full Text] [Related]
8. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
Lowe NJ
Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
[TBL] [Abstract][Full Text] [Related]
10. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.
Michaels BM; Csank GA; Ryb GE; Eko FN; Rubin A
Aesthet Surg J; 2012 Jan; 32(1):96-102. PubMed ID: 22231417
[TBL] [Abstract][Full Text] [Related]
12. Botox for rejuvenation of the periorbital region.
Frankel AS
Facial Plast Surg; 1999; 15(3):255-62. PubMed ID: 11816088
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
Fagien S
Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
[TBL] [Abstract][Full Text] [Related]
14. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
Mantell AM
Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin Type-A (BoNT-A) Injections of the Corrugator Muscles for Aesthetics and Depression?
Brennan C
Plast Surg Nurs; 2016; 36(4):167-169. PubMed ID: 27922559
[TBL] [Abstract][Full Text] [Related]
16. Injectable treatments for the aging face.
Wise JB; Greco T
Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
[TBL] [Abstract][Full Text] [Related]
17. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
Glogau RG
Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of IncobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot study.
Gubanova EI; Panova OS; Sanchez EA; Rodina MY; Starovatova PA
J Drugs Dermatol; 2013 Dec; 12(12):1461-6. PubMed ID: 24301249
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
Matarasso A; Shafer D
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
